Name | Pegaptanib sodium |
---|
Description | Pegaptanib sodium is an RNA aptamer directed against vascular endothelial growth factor (VEGF)-165. Pegaptanib could be used for the study of neovascular age-related macular degeneration (AMD) [1]. |
---|---|
Related Catalog | |
In Vitro | Pegaptanib also inhibits VEGF165-mediated phosphorylation of VEGFR2 and phospholipase Cγ and inhibited VEGF165-induced calcium mobilization in human umbilical vein endothelial cells[1]. |
References |
No Any Chemical & Physical Properties |